The FASEB Journal · 2019 · 16 citations · 34 references
Life SciencesCell BiologyMolecular BiologyCell SignalingLipid BiochemistrySignal TransductionLipid MetabolismLipid SignalingLipid-protein InteractionsProtein-lipid InteractionsMembrane Lipid SignalingPharmacological DisruptionPhosphatidic Acid SignalingPhosphatidylinositol 4, 5-BisphosphatePhosphoinositide PhosphatasesPhospholipase D PathwayVascular RemodelingVascular Smooth Muscle Regulation
Very little is known about how lipid signaling regulates intima hyperplasia after vascular injury. Herein, we report that deletion and pharmacological inhibition of phospholipase D (PLD)2, which generates the signaling lipid phosphatidic acid (PA), reduced neointimal formation in the mouse carotid artery ligation model. PLD2 deficiency inhibits migration of vascular smooth muscle cells (VSMCs) into the intima in mice as well as migration and formation of membrane ruffles in primary VSMCs. PA specifically binds to the IQ motif-containing guanosine triphosphatase-activating protein 1 (IQGAP1) scaffold protein. The binding between PA and IQGAP is required for the plasma membrane recruitment of IQGAP1. Similar to PLD2 inhibition, knockdown of IQGAP1 blocks ruffle formation and migration in VSMCs, which are rescued by expression of the exogenous IQGAP1 but not the PA binding-deficient mutant. These data reveal that the PLD2-PA-IQGAP1 pathway plays an important role in VSMC migration and injury-induced vascular remodeling, and implicate PLD2 as a candidate target for therapeutic interventions.-Wang, Z., Cai, M., Tay, L. W. R., Zhang, F., Wu, P., Huynh, A., Cao, X., Di Paolo, G., Peng, J., Milewicz, D. M., Du, G. Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation.
34
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
Type I Phosphatidylinositol-4-phosphate 5-Kinases
Hisamitsu Ishihara, Yoshikazu Shibasaki, Nobuaki Kizuki et al. · Journal of Biological Chemistry · 1998 · 288 citations · Full text
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness
Sarah Scott, Paige E. Selvy, Jason R. Buck et al. · Nature Chemical Biology · 2009 · 273 citations · Full text
Medicine, Oncology, Pharmacology +12